These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 36924905)
21. The cyclin-dependent kinase inhibitor SNS-032 has single agent activity in AML cells and is highly synergistic with cytarabine. Walsby E; Lazenby M; Pepper C; Burnett AK Leukemia; 2011 Mar; 25(3):411-9. PubMed ID: 21212792 [TBL] [Abstract][Full Text] [Related]
22. Inhibition of Nrf2-mediated glucose metabolism by brusatol synergistically sensitizes acute myeloid leukemia to Ara-C. Cheng C; Yuan F; Chen XP; Zhang W; Zhao XL; Jiang ZP; Zhou HH; Zhou G; Cao S Biomed Pharmacother; 2021 Oct; 142():111652. PubMed ID: 34112534 [TBL] [Abstract][Full Text] [Related]
23. Inhibition of Sp1-mediated survivin and MCL1 expression cooperates with SLC35F2 and myeloperoxidase to modulate YM155 cytotoxicity to human leukemia cells. Chiou JT; Lee YC; Huang CH; Wang LJ; Shi YJ; Chang LS Biochem Pharmacol; 2021 Jun; 188():114544. PubMed ID: 33831396 [TBL] [Abstract][Full Text] [Related]
24. Induction of cytosine arabinoside-resistant human myeloid leukemia cell death through autophagy regulation by hydroxychloroquine. Kim Y; Eom JI; Jeung HK; Jang JE; Kim JS; Cheong JW; Kim YS; Min YH Biomed Pharmacother; 2015 Jul; 73():87-96. PubMed ID: 26211587 [TBL] [Abstract][Full Text] [Related]
25. Albendazole-Induced SIRT3 Upregulation Protects Human Leukemia K562 Cells from the Cytotoxicity of MCL1 Suppression. Wang LJ; Liou LR; Shi YJ; Chiou JT; Lee YC; Huang CH; Huang PW; Chang LS Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486166 [TBL] [Abstract][Full Text] [Related]
26. Synergistic activity and mechanism of cytarabine and MCL-1 inhibitor AZD5991 against acute myeloid leukemia. Wang Y; Wang D; Wang Y; Yang H; Wang G; Wu S Neoplasma; 2023 Apr; 70(2):287-293. PubMed ID: 36812234 [TBL] [Abstract][Full Text] [Related]
27. Inhibition of Mnk enhances apoptotic activity of cytarabine in acute myeloid leukemia cells. Li P; Diab S; Yu M; Adams J; Islam S; Basnet SK; Albrecht H; Milne R; Wang S Oncotarget; 2016 Aug; 7(35):56811-56825. PubMed ID: 27462781 [TBL] [Abstract][Full Text] [Related]
28. Effect of 1-beta-D-arabinofuranosylcytosine on apoptosis and differentiation in human monocytic leukemia cells (U937) expressing a c-Jun dominant-negative mutant protein (TAM67). Grant S; Freemerman AJ; Birrer MJ; Martin HA; Turner AJ; Szabo E; Chelliah J; Jarvis WD Cell Growth Differ; 1996 May; 7(5):603-13. PubMed ID: 8732670 [TBL] [Abstract][Full Text] [Related]
29. HOTAIRM1 knockdown enhances cytarabine-induced cytotoxicity by suppression of glycolysis through the Wnt/β-catenin/PFKP pathway in acute myeloid leukemia cells. Chen L; Hu N; Wang C; Zhao H Arch Biochem Biophys; 2020 Feb; 680():108244. PubMed ID: 31904363 [TBL] [Abstract][Full Text] [Related]
30. Emodin and Its Combination with Cytarabine Induce Apoptosis in Resistant Acute Myeloid Leukemia Cells in Vitro and in Vivo. Chen Y; Gan D; Huang Q; Luo X; Lin D; Hu J Cell Physiol Biochem; 2018; 48(5):2061-2073. PubMed ID: 30099447 [TBL] [Abstract][Full Text] [Related]
31. Confounding off-target effects of BH3 mimetics at commonly used concentrations: MIM1, UMI-77, and A-1210477. Mallick DJ; Soderquist RS; Bates D; Eastman A Cell Death Dis; 2019 Feb; 10(3):185. PubMed ID: 30796196 [TBL] [Abstract][Full Text] [Related]
32. Bryostatin 1 and UCN-01 potentiate 1-beta-D-arabinofuranosylcytosine-induced apoptosis in human myeloid leukemia cells through disparate mechanisms. Wang S; Wang Z; Grant S Mol Pharmacol; 2003 Jan; 63(1):232-42. PubMed ID: 12488556 [TBL] [Abstract][Full Text] [Related]
33. CDK4/6 Inhibitor PD 0332991 Sensitizes Acute Myeloid Leukemia to Cytarabine-Mediated Cytotoxicity. Yang C; Boyson CA; Di Liberto M; Huang X; Hannah J; Dorn DC; Moore MA; Chen-Kiang S; Zhou P Cancer Res; 2015 May; 75(9):1838-45. PubMed ID: 25744718 [TBL] [Abstract][Full Text] [Related]
34. Evidence of a functional role for the cyclin-dependent kinase inhibitor p21CIP1 in leukemic cell (U937) differentiation induced by low concentrations of 1-beta-D-arabinofuranosylcytosine. Wang Z; Wang S; Fisher PB; Dent P; Grant S Differentiation; 2000 Aug; 66(1):1-13. PubMed ID: 10997587 [TBL] [Abstract][Full Text] [Related]
35. Naja nigricollis CMS-9 enhances the mitochondria-mediated death pathway in adaphostin-treated human leukaemia U937 cells. Chen YJ; Wang JJ; Chang LS Clin Exp Pharmacol Physiol; 2011 Nov; 38(11):755-63. PubMed ID: 21824174 [TBL] [Abstract][Full Text] [Related]
36. Carboxyl Group-Modified Myoglobin Induces TNF-α-Mediated Apoptosis in Leukemia Cells. Lee YC; Chiou JT; Wang LJ; Shi YJ; Chen YJ; Chang LS Pharmaceuticals (Basel); 2022 Aug; 15(9):. PubMed ID: 36145287 [TBL] [Abstract][Full Text] [Related]
37. Inducer-and cell type-specific regulation of antiapoptotic MCL1 in myeloid leukemia and multiple myeloma cells exposed to differentiation-inducing or microtubule-disrupting agents. Vrana JA; Cleaveland ES; Eastman A; Craig RW Apoptosis; 2006 Aug; 11(8):1275-88. PubMed ID: 16761109 [TBL] [Abstract][Full Text] [Related]
38. Long noncoding RNA DANCR confers cytarabine resistance in acute myeloid leukemia by activating autophagy via the miR-874-3P/ATG16L1 axis. Zhang H; Liu L; Chen L; Liu H; Ren S; Tao Y Mol Oncol; 2021 Apr; 15(4):1203-1216. PubMed ID: 33638615 [TBL] [Abstract][Full Text] [Related]
39. ABT-263-induced MCL1 upregulation depends on autophagy-mediated 4EBP1 downregulation in human leukemia cells. Lee YC; Wang LJ; Huang CH; Shi YJ; Chang LS Cancer Lett; 2018 Sep; 432():191-204. PubMed ID: 29913235 [TBL] [Abstract][Full Text] [Related]
40. The Association Between p38 MAPK-Mediated TNF-α/TNFR2 up-Regulation and 2-(4-Aminophenyl)-7-Methoxybenzothiazole-Induced Apoptosis in Human Leukemia U937 Cells. Huang CH; Chen YJ; Chao TY; Liu WH; Changchien JJ; Hu WP; Chang LS J Cell Physiol; 2016 Jan; 231(1):130-41. PubMed ID: 26059963 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]